Andrew Witty

Latest articles

10d
Hampshire Chronicle
GlaxoSmithKline falls to bottom of good governance surveypayments to doctors in China in a bid to boost sales, as well as controversy ov
Hampshire Chronicle / Posted 10 days ago
payments to doctors in China in a bid to boost sales, as well as controversy over executive pay after former chief Sir Andrew Witty saw his salary surge despite a drop in earnings. The pay package for new GSK chief executive Emma Walmsley was... Read more
22 related articles
10d
This is Oxfordshire
GlaxoSmithKline falls to bottom of good governance surveypayments to doctors in China in a bid to boost sales, as well as controversy ov
This is Oxfordshire / Posted 10 days ago
payments to doctors in China in a bid to boost sales, as well as controversy over executive pay after former chief Sir Andrew Witty saw his salary surge despite a drop in earnings. The pay package for new GSK chief executive Emma Walmsley was... Read more
22 related articles
10d
Lancashire Telegraph
GlaxoSmithKline falls to bottom of good governance surveypayments to doctors in China in a bid to boost sales, as well as controversy ov
Lancashire Telegraph / Posted 10 days ago
payments to doctors in China in a bid to boost sales, as well as controversy over executive pay after former chief Sir Andrew Witty saw his salary surge despite a drop in earnings. The pay package for new GSK chief executive Emma Walmsley was... Read more
22 related articles
10d
West Moreland Gazette
GlaxoSmithKline falls to bottom of good governance surveypayments to doctors in China in a bid to boost sales, as well as controversy ov
West Moreland Gazette / Posted 10 days ago
payments to doctors in China in a bid to boost sales, as well as controversy over executive pay after former chief Sir Andrew Witty saw his salary surge despite a drop in earnings. The pay package for new GSK chief executive Emma Walmsley was... Read more
22 related articles
10d
Oxford Mail
GlaxoSmithKline falls to bottom of good governance surveypayments to doctors in China in a bid to boost sales, as well as controversy ov
Oxford Mail / Posted 10 days ago
payments to doctors in China in a bid to boost sales, as well as controversy over executive pay after former chief Sir Andrew Witty saw his salary surge despite a drop in earnings. The pay package for new GSK chief executive Emma Walmsley was... Read more
22 related articles
10d
Bury Times
GlaxoSmithKline falls to bottom of good governance surveypayments to doctors in China in a bid to boost sales, as well as controversy ov
Bury Times / Posted 10 days ago
payments to doctors in China in a bid to boost sales, as well as controversy over executive pay after former chief Sir Andrew Witty saw his salary surge despite a drop in earnings. The pay package for new GSK chief executive Emma Walmsley was... Read more
22 related articles
10d
Gazette
GlaxoSmithKline falls to bottom of good governance surveypayments to doctors in China in a bid to boost sales, as well as controversy ov
Gazette / Posted 10 days ago
payments to doctors in China in a bid to boost sales, as well as controversy over executive pay after former chief Sir Andrew Witty saw his salary surge despite a drop in earnings. The pay package for new GSK chief executive Emma Walmsley was... Read more
22 related articles
10d
guardian-series
GlaxoSmithKline falls to bottom of good governance surveypayments to doctors in China in a bid to boost sales, as well as controversy ov
guardian-series / Posted 10 days ago
payments to doctors in China in a bid to boost sales, as well as controversy over executive pay after former chief Sir Andrew Witty saw his salary surge despite a drop in earnings. The pay package for new GSK chief executive Emma Walmsley was... Read more
22 related articles
10d
Greenock Telegraph
GlaxoSmithKline falls to bottom of good governance surveypayments to doctors in China in a bid to boost sales, as well as controversy ov
Greenock Telegraph / Posted 10 days ago
payments to doctors in China in a bid to boost sales, as well as controversy over executive pay after former chief Sir Andrew Witty saw his salary surge despite a drop in earnings. The pay package for new GSK chief executive Emma Walmsley was... Read more
22 related articles
10d
Harrow Times
GlaxoSmithKline falls to bottom of good governance surveypayments to doctors in China in a bid to boost sales, as well as controversy ov
Harrow Times / Posted 10 days ago
payments to doctors in China in a bid to boost sales, as well as controversy over executive pay after former chief Sir Andrew Witty saw his salary surge despite a drop in earnings. The pay package for new GSK chief executive Emma Walmsley was... Read more
22 related articles
10d
This is West Country
GlaxoSmithKline falls to bottom of good governance surveypayments to doctors in China in a bid to boost sales, as well as controversy ov
This is West Country / Posted 10 days ago
payments to doctors in China in a bid to boost sales, as well as controversy over executive pay after former chief Sir Andrew Witty saw his salary surge despite a drop in earnings. The pay package for new GSK chief executive Emma Walmsley was... Read more
22 related articles
10d
Gazette News
GlaxoSmithKline falls to bottom of good governance surveypayments to doctors in China in a bid to boost sales, as well as controversy ov
Gazette News / Posted 10 days ago
payments to doctors in China in a bid to boost sales, as well as controversy over executive pay after former chief Sir Andrew Witty saw his salary surge despite a drop in earnings. The pay package for new GSK chief executive Emma Walmsley was... Read more
22 related articles
10d
Bolton News
GlaxoSmithKline falls to bottom of good governance surveypayments to doctors in China in a bid to boost sales, as well as controversy ov
Bolton News / Posted 10 days ago
payments to doctors in China in a bid to boost sales, as well as controversy over executive pay after former chief Sir Andrew Witty saw his salary surge despite a drop in earnings. The pay package for new GSK chief executive Emma Walmsley was... Read more
22 related articles
10d
St Albans & Harpenden Review
GlaxoSmithKline falls to bottom of good governance surveypayments to doctors in China in a bid to boost sales, as well as controversy ov
St Albans & Harpenden Review / Posted 10 days ago
payments to doctors in China in a bid to boost sales, as well as controversy over executive pay after former chief Sir Andrew Witty saw his salary surge despite a drop in earnings. The pay package for new GSK chief executive Emma Walmsley was... Read more
22 related articles
10d
Wandsworth Guardian
GlaxoSmithKline falls to bottom of good governance surveypayments to doctors in China in a bid to boost sales, as well as controversy ov
Wandsworth Guardian / Posted 10 days ago
payments to doctors in China in a bid to boost sales, as well as controversy over executive pay after former chief Sir Andrew Witty saw his salary surge despite a drop in earnings. The pay package for new GSK chief executive Emma Walmsley was... Read more
22 related articles
10d
EveningTimes Online
GlaxoSmithKline falls to bottom of good governance surveypayments to doctors in China in a bid to boost sales, as well as controversy ov
EveningTimes Online / Posted 10 days ago
payments to doctors in China in a bid to boost sales, as well as controversy over executive pay after former chief Sir Andrew Witty saw his salary surge despite a drop in earnings. The pay package for new GSK chief executive Emma Walmsley was... Read more
22 related articles
10d
Croydon Guardian
GlaxoSmithKline falls to bottom of good governance surveypayments to doctors in China in a bid to boost sales, as well as controversy ov
Croydon Guardian / Posted 10 days ago
payments to doctors in China in a bid to boost sales, as well as controversy over executive pay after former chief Sir Andrew Witty saw his salary surge despite a drop in earnings. The pay package for new GSK chief executive Emma Walmsley was... Read more
22 related articles

In this news